APA (7th ed.) Citation

van Berge Henegouwen, J. M., van der Wijngaart, H., Zeverijn, L. J., Hoes, L. R., Meertens, M., Huitema, A. D. R., . . . Gelderblom, H. (2022). Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: A case series and review of literature. Cancer Chemotherapy & Pharmacology, 90(1), 97. https://doi.org/10.1007/s00280-022-04437-z

Chicago Style (17th ed.) Citation

van Berge Henegouwen, J. M., et al. "Efficacy and Toxicity of Vemurafenib and Cobimetinib in Relation to Plasma Concentrations, After Administration via Feeding Tube in Patients with BRAF-mutated Thyroid Cancer: A Case Series and Review of Literature." Cancer Chemotherapy & Pharmacology 90, no. 1 (2022): 97. https://doi.org/10.1007/s00280-022-04437-z.

MLA (9th ed.) Citation

van Berge Henegouwen, J. M., et al. "Efficacy and Toxicity of Vemurafenib and Cobimetinib in Relation to Plasma Concentrations, After Administration via Feeding Tube in Patients with BRAF-mutated Thyroid Cancer: A Case Series and Review of Literature." Cancer Chemotherapy & Pharmacology, vol. 90, no. 1, 2022, p. 97, https://doi.org/10.1007/s00280-022-04437-z.